SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001590750-24-000012
Filing Date
2024-05-08
Accepted
2024-05-08 07:51:21
Documents
70
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vrdn-20240331.htm   iXBRL 10-Q 1350118
2 EX-31.1 ex311_2024-03.htm EX-31.1 11371
3 EX-31.2 ex312_2024-03.htm EX-31.2 12573
4 EX-32.1 ex321_2024-03.htm EX-32.1 9349
  Complete submission text file 0001590750-24-000012.txt   6992934

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrdn-20240331.xsd EX-101.SCH 44747
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrdn-20240331_cal.xml EX-101.CAL 55130
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrdn-20240331_def.xml EX-101.DEF 287579
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrdn-20240331_lab.xml EX-101.LAB 658986
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrdn-20240331_pre.xml EX-101.PRE 465844
74 EXTRACTED XBRL INSTANCE DOCUMENT vrdn-20240331_htm.xml XML 805380
Mailing Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36483 | Film No.: 24924284
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)